Virus News and Research

Latest Virus News and Research

The case for vaccinating children under 12 against COVID-19

Researchers assess the need for coronavirus disease 2019 (COVID-19) vaccination in children who are 12 years of age or younger.

14 Nov 2021

Increased risk of breakthrough SARS-CoV-2 infection with ChAdOx1 compared to BNT162b2 vaccine

Researchers study individuals recruited in the ‘Virus Watch’ community cohort who had received their second dose of either ChAdOx1 or BNT162b2 vaccine.

14 Nov 2021

Partial resistance to neutralizing antibodies and enhanced transmissibility of SARS-CoV-2 Delta variant

A new study estimates the efficacy of the immune response induced by vaccination and natural COVID-19 infection against the Kappa and Delta lineages.

14 Nov 2021

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

A novel study is assessing whether medicinal mushrooms and Chinese herbs provide therapeutic benefit in treating acute COVID-19 infection.

12 Nov 2021

Rugby figures urge people to get vaccinated and take action to reduce COVID-19 transmission

Rugby figures are urging people to get vaccinated and take action, including ventilating indoors spaces, to cut COVID-19 transmission in a new film which will be shown to rugby fans at one of the most anticipated games of the Autumn Nations Series today (Saturday November 13).

12 Nov 2021

Recipe to decontaminate disposable facemasks

Here's the recipe to decontaminate a disposable facemask: Heat it at 160 degrees Fahrenheit in an oven for five minutes. You can use your own oven.

12 Nov 2021

New findings about naturally acquired immunity may help improve existing malaria vaccines

When you have become immune to malaria after having contracted the disease, it seems that the body uses a more efficient protection than if you have been vaccinated against the deadly disease.

12 Nov 2021

Researchers develop a rapid, non-invasive exhaled breath screening system for COVID-19

At present, the COVID-19 pandemic is still ongoing in many parts of the world, causing severe socio-economic problems.

12 Nov 2021

SARS-CoV-2 self-amplifying mRNA vaccine demonstrates cellular and humoral immune responses

Researchers from the US recently reported the preclinical development of a self-amplifying mRNA (SAM) vaccine that encodes a prefusion-stabilized SARS-CoV-2 spike glycoprotein.

12 Nov 2021

Xanthohumol as a potent pan-inhibitor for various coronaviruses

Researchers from China reported the results of their study aimed at finding an effective Mpro inhibitor since Mpro is the best drug target to fight SARS-CoV-2 infection.

12 Nov 2021

Impact of mutations on binding affinity of SARS-CoV-2 variants with ACE2 and existing antibodies

Researchers explained their analysis of the mechanisms that trigger the docking of SARS-CoV-2 variants to ACE2 and the antibodies, referred to as protein-protein docking.

12 Nov 2021

How safe is it to travel on public transport amid COVID-19?

The authors extended this research by proposing a time-varying weighted Public Transportation Encounter Network that modeled the COVID-19 infectious process observed on public transport.

12 Nov 2021

INTEGRA’s VOYAGER helps HIV researchers get more results in significantly less time

INTEGRA’s VOYAGER adjustable tip spacing pipette is supporting crucial experimental work in longitudinal HIV studies.

From INTEGRA Biosciences 12 Nov 2021

Study may pave the way for a more personalized approach to COVID-19 diagnosis and treatment

Using some of the most advanced molecular sequencing tools available to evaluate COVID-19 rapid autopsy tissues, researchers have identified four major regulatory pathways, specific molecular effectors behind COVID-19 symptoms, and differences that drive diverging clinical courses among individual patients.

11 Nov 2021

Virus News and Research

Latest Virus News and Research

The case for vaccinating children under 12 against COVID-19

Increased risk of breakthrough SARS-CoV-2 infection with ChAdOx1 compared to BNT162b2 vaccine

Partial resistance to neutralizing antibodies and enhanced transmissibility of SARS-CoV-2 Delta variant

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

Rugby figures urge people to get vaccinated and take action to reduce COVID-19 transmission

Recipe to decontaminate disposable facemasks

New findings about naturally acquired immunity may help improve existing malaria vaccines

Researchers develop a rapid, non-invasive exhaled breath screening system for COVID-19

SARS-CoV-2 self-amplifying mRNA vaccine demonstrates cellular and humoral immune responses

Xanthohumol as a potent pan-inhibitor for various coronaviruses

Impact of mutations on binding affinity of SARS-CoV-2 variants with ACE2 and existing antibodies

How safe is it to travel on public transport amid COVID-19?

INTEGRA’s VOYAGER helps HIV researchers get more results in significantly less time

Study may pave the way for a more personalized approach to COVID-19 diagnosis and treatment

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

Research shows link between exercise and better mental health

UK Government opens large COVID testing facility in Edinburgh

More than 11.4 million people in the UK receive COVID-19 booster jabs

University of Oxford begins Phase I trial to test Ebola vaccine

New Delta sublineage shows no additional resistance to neutralization

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in